Patients diagnosed with inflammatory bowel disease in childhood attain a lower adult height than their peers without IBD, according to study results. Natalia Mouratidou, MD, of Astrid Lindgren Children’s Hospital in...

In this guest commentary, Anita Afzali, MD, medical director of the Inflammatory Bowel Disease Center at The Ohio State University Wexner Medical Center, discusses the highlights from the recent IBD Horizons conference held Feb....

The Crohn’s and Colitis Foundation issued guidelines for patients with IBD to protect themselves from COVID-19 such as talk with their gastroenterologist about medications, their health status and any precautions they...

Patients who adhere to health lifestyle choices, including those related to diet, exercise and smoking habits, had reduced mortality, according to study results. Ashwin N. Ananthakrishnan, MD, MPH, of the division of...

MAUI, Hawaii — Interleukin-23 inhibitors are effective for induction and maintenance of remission in Crohn’s disease and ulcerative colitis, according to an expert at the GUILD Conference 2020. “So we have all...

Researchers found a link between frailty and risk for infection following immunosuppression in patients with inflammatory bowel disease after adjusting for age and comorbidities. “Since infections and infection-related...

Despite progress in treatment for inflammatory bowel disease, patients and providers reported differing expectations as to remission and other aspects of disease control in a recent global survey, as presented in a poster during...